Loading...

Policy Statements

Ending stigma and discrimination – everyone deserves dignity and care for liver health

  • Chiara Hartmann

Stigma and discrimination fuel health disparities and worsen outcomes for individuals with liver disease. To address these challenges, we must shift the focus from individual blame to the broader social determinants of health. Learning from successful approaches in HIV, mental health, diabetes, and cancer, we must implement targeted interventions that reduce stigma, expand healthcare access, and promote equity.
Full version of Policy Statement

Read more

EASL Policy Statement: Reducing alcohol harms

Geneva, June 2023: The aim of this European Association for the Study of the Liver (EASL) policy statement is to: 1. Urge policy-makers to reduce health-related, social and economic harms caused by alcohol by implementing evidence-based policies to reduce alcohol…

Read more

EASL Policy Statement on Liver Cancer Screening

Geneva, 27 May 2022: In Europe, the number of deaths from liver cancer has doubled in the past 30 years. Screening for liver cancer with an ultrasound examination every six months is an established method to reduce mortality resulting from…

Read more

Policy statement on drug use and the global hepatitis C elimination goal

  • Adonia DHANJAL

WHO has set a goal of eliminating the hepatitis C virus (HCV) by 2030 but the achievement of this goal is challenged by people who inject drugs (PWID), who account for most of the new cases of HCV infection in high-income countries.

In order to achieve the 2030 WHO viral hepatitis elimination goals, EASL recommends: that all barriers to the uptake of healthcare services by PWID be removed by changing policies and discrimination that hinder access. This includes the decriminalisation of minor, non-violent drug offences and the adoption of an approach based on public health promotion, respect for human rights and evidence.
Full version of Policy Statement

Read more
Share
Back To Top